ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 289 filers reported holding ICU MED INC in Q4 2021. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $20,241,087 | -16.1% | 122,703 | -23.4% | 0.89% | +2.4% |
Q3 2022 | $24,134,000 | -39.4% | 160,250 | -33.8% | 0.87% | -42.5% |
Q2 2022 | $39,813,000 | -18.9% | 242,185 | +9.8% | 1.52% | -17.3% |
Q1 2022 | $49,111,000 | -6.2% | 220,587 | 0.0% | 1.84% | +3.0% |
Q4 2021 | $52,354,000 | +1.7% | 220,587 | 0.0% | 1.78% | +17.8% |
Q3 2021 | $51,481,000 | -2.2% | 220,587 | -13.7% | 1.51% | -8.2% |
Q2 2021 | $52,625,000 | -28.7% | 255,708 | -28.9% | 1.65% | -26.9% |
Q1 2021 | $73,847,000 | +28.6% | 359,461 | +34.2% | 2.26% | +11.6% |
Q4 2020 | $57,444,000 | +3.7% | 267,817 | -11.6% | 2.02% | -21.1% |
Q3 2020 | $55,376,000 | -9.7% | 302,999 | -8.9% | 2.56% | -19.5% |
Q2 2020 | $61,329,000 | +50.2% | 332,751 | +64.5% | 3.18% | -5.1% |
Q1 2020 | $40,826,000 | +31.7% | 202,339 | +22.1% | 3.35% | +127.0% |
Q4 2019 | $30,999,000 | -68.2% | 165,665 | -57.1% | 1.48% | -20.2% |
Q2 2019 | $97,386,000 | +8.6% | 386,592 | +3.1% | 1.85% | -6.7% |
Q1 2019 | $89,715,000 | +122.3% | 374,860 | +113.3% | 1.98% | +85.0% |
Q4 2018 | $40,359,000 | – | 175,758 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |